Correlation Between Brinker International and Collegium Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Brinker International and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brinker International and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Brinker International and Collegium Pharmaceutical, you can compare the effects of market volatilities on Brinker International and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brinker International with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brinker International and Collegium Pharmaceutical.

Diversification Opportunities for Brinker International and Collegium Pharmaceutical

-0.88

Correlation Coefficient

Brinker International  Collegium Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Brinker and Collegium is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Brinker International and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Brinker International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brinker International are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Brinker International i.e., Brinker International and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Brinker International and Collegium Pharmaceutical

Considering the 90-day investment horizon Brinker International is expected to generate 1.02 times more return on investment than Collegium Pharmaceutical. However, Brinker International is 1.02 times more volatile than Collegium Pharmaceutical. It trades about 0.43 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.13 per unit of risk. If you would invest  7,121  in Brinker International on September 1, 2024 and sell it today you would earn a total of  6,106  from holding Brinker International or generate 85.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Brinker International  vs.  Collegium Pharmaceutical

Brinker International

Risk-Adjusted Performance

33 of 100

Very Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Brinker International are ranked lower than 33 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Brinker International unveiled solid returns over the last few months and may actually be approaching a breakup point.

Collegium Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Brinker International and Collegium Pharmaceutical

The main advantage of trading using opposite Brinker International and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brinker International position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.

The idea behind Brinker International and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.